Cassian Yee, MD
Enriched profileProfessor, Department of Melanoma Medical Oncology and Department of Immunology; Director, Program for T Cell-Based Therapies (ProTCT) · The University of Texas MD Anderson Cancer Center
Cassian Yee is Professor, Department of Melanoma Medical Oncology and Department of Immunology; Director, Program for T Cell-Based Therapies (ProTCT) at The University of Texas MD Anderson Cancer Center. OpenAlex indexes 349 publications with 18,286 citations (h-index 65); ClinicalTrials.gov lists 10 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 2 Sept 2026
Cassian Yee, MD, is Professor, Department of Melanoma Medical Oncology and Department of Immunology at The University of Texas MD Anderson Cancer Center. The public record shows 349 publications with 18,286 citations (h-index 65), centered on CAR-T cell therapy research, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 3 companies, 7 NIH-funded awards (2013–2025).
- Most recent indexed publication: 2026 · Nature communications
- Top research focus: CAR-T cell therapy research
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 2 Sept 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 23 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 144.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 2 Sept 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Adoptive Therapy Using Antigen-Specific CD4 T-Cells
Sponsor: M.D. Anderson Cancer Center
- Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma
Sponsor: Fred Hutchinson Cancer Center
- Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic Melanoma
Sponsor: Fred Hutchinson Cancer Center
Industry payments
Updated 2 Sept 2026
3 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:
- Janssen Research & Development, LLCProgram year20251 payment
- Merck Sharp & Dohme LLCProgram year20241 payment$12,200openpaymentsdata.cms.gov ↗
- Immunocore LimitedProgram year20231 payment
NIH funding
Updated 2 Sept 2026
7 NIH research awards on record, funded 2013–2025 per NIH RePORTER. The latest:
- HORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer
University of Tx Md Anderson Can Ctr
FY2025$2,270,520UH3CA283615 - Project 2: Adoptive Cell Therapies for Chordomas
University of Tx Md Anderson Can Ctr
FY2025$319,676P50CA302482 - HORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer
University of Tx Md Anderson Can Ctr
FY2024$1,310,673UG3CA283615
Congress activity
Updated 2 Sept 2026
44 congress contributions (2010–2025) across AACR, ASCO, ASH, ESMO per OpenAlex. The most recent:
- Machine learning–driven approaches for predicting T-cell–mediated immunity and beyond.
ASCO Annual Meeting
ASCO2025Co-author - Abstract 1146: Pan-cancer characterization of cancer cell state and plasticity using spatially resolved transcriptomics
AACR Annual Meeting
AACR2024Co-author - Abstract 24: Utilizing T cell receptor-based therapy to treat anaplastic thyroid cancer
AACR Annual Meeting
AACR2024Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 2 Sept 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Deciphering small sequence differences in T cell receptor-antigen pairing.
Nature communications
Article2026 - FOXM1-Specific TCR-Engineered T Cells Target Non-Small Cell Lung Cancer.
Cancer immunology research
Article2026 - The E2F1-HMGCR axis promotes ferroptosis resistance in immune refractory tumor cells.
Nature communications
Article2025 - Urine proteomics defines an immune checkpoint-associated nephritis signature.
Journal for immunotherapy of cancer
Article2025
Most-cited works
by citation count (OpenAlex)Network
Updated 2 Sept 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 2 Sept 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/profile/Cassian-Yee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/cassian-yee-6140764
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/in/cassianyee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 2 Sept 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Fellowship
Hematology and Medical Oncology, University of Washington / Fred Hutchinson Cancer Research Center
1998verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Editorial & leadership roles
journal and society appointments- Director
Program for T Cell-Based Therapies (ProTCT)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗ - Co-Director
Adoptive Cellular Therapy Platform; Director, Solid Tumor Cell Therapy Program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdanderson.org ↗ - Editorial Board member
Cancer Immunology Research, Journal of Translational Medicine, and OncoImmunology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Secondary affiliations
appointments beyond the home institution- Graduate faculty
UTHealth Houston Graduate School of Biomedical Sciences (GSBS)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →gsbs.uth.edu ↗ - CPRIT Scholar
Cancer Prevention and Research Institute of Texas
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cprit.texas.gov ↗
Media & interviews
press, podcasts and appearances- "Sarcoma Awareness Month: Tackling Chordoma with Dr. Cassian Yee" - Q&A interview
Cancer Research Institute blog
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancerresearch.org ↗ - Speaker Interview at the 7th TCR-Based Therapies Summit
discussing TCR engineering and solid tumor cell therapy advances
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tcr-therapies-summit.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center